INSIGHTS ON DRUG DEVELOPMENT
-
![Thermo - next gen disease models webinar]( "Next-Gen Disease Models And Cell Therapeutics: Innovations In AI, Omics And Collaboration")
Next-Gen Disease Models And Cell Therapeutics: Innovations In AI, Omics And CollaborationLearn how to leverage AI, omics integration, and collaborative research to build more physiologically relevant disease models and accelerate the development of next-gen cell therapies.
-
![Cy Credille]( "Ask Us Anything: Cy Credille")
Ask Us Anything: Cy CredilleLearn how we balance discovery and development as an asset scales, and how the One Cambrex model keeps the original process scientists attached to a molecule from first kilos through NDA.
-
![vaccine, disease prevention-GettyImages-1155084813]( "Neoantigen-Based Personalized Cancer Vaccine")
Neoantigen-Based Personalized Cancer VaccinePersonalized cancer vaccines are advancing quickly, but effective delivery remains a major hurdle. Learn how mRNA and lipid nanoparticle design influence targeting, endosomal escape, and repeat dosing.
-
![pharma-partners-GettyImages-2182052451]( "Three Keys To E&L Success: Study Design, Partner Selection, And Timing")
Three Keys To E&L Success: Study Design, Partner Selection, And TimingSuccessful E&L planning starts before testing begins. Aligning study design, partner expertise, and timing helps teams focus on the right risks, avoid surprises, and support stronger development.
-
Little Patients, Big Challenges: Developing Pediatric Formulations5/12/2025
Explore the development of high-quality, child-friendly oral formulations, as well as learn about new testing requirements for impurities and innovative approaches to creating age-appropriate medications.
-
How To Capture Growth In The Expanding Metabolic Drug Market12/2/2025
Driven by GLP-1 success and rising obesity rates, R&D investment in metabolic disease therapies now rivals oncology, demanding rapid development to overcome market challenges.
-
Approaching DoE During Process Characterization7/24/2026
Insights into the validation expertise behind process characterization and how deep problem-solving can turn a process into one robust enough to carry a drug to market.
-
Are You Keeping Pace With Oligo Synthesis Optimization?11/18/2025
The rapidly expanding oligo market demands optimized RNA synthesis. Examine key innovations and workflow insights to maximize resources and control long-term manufacturing costs.
-
In Vivo Testing Of Nasal Dosage Forms5/7/2025
Innovative nasal drug delivery strategies can unlock faster, patient-friendly therapeutic solutions by combining smart formulation, advanced testing platforms, and rigorous preclinical evaluation.
DRUG DEVELOPMENT SOLUTIONS
-
![leica-microsystems-stellaris-8-falcon-hero]( "Lifetime Imaging In An Instant With A FLIM Microscope")
STELLARIS 8 FALCON FLIM Microscope
The contrast is clear. Lifetime imaging in an instant.
STELLARIS 8 FALCON (FAst Lifetime CONtrast) is the future of functional imaging. Harness the power of fluorescence lifetime to investigate cellular physiology and explore dynamics in living cells. STELLARIS 8 FALCON is a fully integrated solution for Fluorescence Lifetime Imaging (FLIM) and enables video-rate lifetime imaging acquisition for rapid kinetic studies in live cells.
STELLARIS 8 FALCON adds a new dimension of contrast to your imaging, opening the door to biosensing and tracking of interactions between proteins. FLIM information is now available for all modalities of the STELLARIS 8 system.
-
![GettyImages-640168692-laboratory-equipment-tablet-quality]( "Addressing Your Requirements For Parenteral Applications")
Ensure patient safety and product efficacy with high-quality pharmaceutical excipients that are designed to streamline regulatory approval and support sterile liquid drug formulation development.
-
![Nanoform]( "GMP Manufacturing")
Nanoform’s GMP facility utilizes its award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology for the manufacture of API nanoparticles to GMP standards.
-
MaxPeak™ Premier Columns utilize MaxPeak High Performance Surfaces that are designed to increase analyte recovery, sensitivity, and reproducibility by minimizing analyte/surface interactions that can lead to sample losses.
-
![cdo key visual image_]( "CDO Services: Agile. Flexible. Focused On You.")
Successful development relies on a deep understanding of a molecule’s unique characteristics. We have the knowledge and expertise to realize the true potential of your molecule, regardless of its complexity.
